On November 17, 2016, the Judge handling the Taxotere (Docetaxel) Products Liability Litigation (MDL 2740) issued Pretrial Order No. 2 appointing counsel as Plaintiffs’ Liaison Counsel, Defendants’ Liaison Counsel and to the Plaintiffs’ Steering Committee. All appointments are for a 1 year term beginning immediately until January 1, 2018. Applications for the subsequent term must be...
Taxotere® Litigation: Ohio Breast Cancer Survivor Now Takes On Sanofi-Aventis
Temporary hair loss following chemotherapy is hard enough. Unfortunately, as acknowledged by the FDA, cases of permanent hair loss (alopecia) have been reported in patients who have been given the chemotherapy drug, Taxotere®. Now a breast cancer survivor from Ohio, Hattie Carson, has decided to take on Sanofi-Aventis in Ohio Federal Court. According to her complaint, Ms. Carson underwent...